Escherichia coli isolates commonly inhabit
the
human microbiota, yet the majority of E. coli’s
small-molecule repertoire remains uncharacterized. We previously employed
erythromycin-induced translational stress to facilitate the characterization
of autoinducer-3 (AI-3) and structurally related pyrazinones derived
from “abortive” tRNA synthetase reactions in pathogenic,
commensal, and probiotic E. coli isolates. In this
study, we explored the “missing” tryptophan-derived
pyrazinone reaction and characterized two other families of metabolites
that were similarly upregulated under erythromycin stress. Strikingly,
the abortive tryptophanyl-tRNA synthetase reaction leads to a tetracyclic
indole alkaloid metabolite (1) rather than a pyrazinone.
Furthermore, erythromycin induced two naphthoquinone-functionalized
metabolites (MK-hCys, 2; and MK-Cys, 3)
and four lumazines (7–10). Using
genetic and metabolite analyses coupled with biomimetic synthesis,
we provide support that the naphthoquinones are derived from 4-dihydroxy-2-naphthoic
acid (DHNA), an intermediate in the menaquinone biosynthetic pathway,
and the amino acids homocysteine and cysteine. In contrast, the lumazines
are dependent on a flavin intermediate and α-ketoacids from
the aminotransferases AspC and TyrB. We show that one of the lumazine
members (9), an indole-functionalized analogue, possesses
antioxidant properties, modulates the anti-inflammatory fate of isolated
TH17 cells, and serves as an aryl-hydrocarbon receptor
(AhR) agonist. These three systems described here serve to illustrate
that new metabolic branches could be more commonly derived from well-established
primary metabolic pathways.